-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation